MarketInOut Stock Screener Log In | Sign Up

Colinz Laboratories Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:53
Colinz Laboratories Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization170.04 mln
Float0.79 mln

EPS

11.10
Robust

P / E

6.22
Undervalued

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-3.39
Reliable

Relative Strength

66 / 100
Outperforming

Debt / Equity

0.04
Debt-free

Business Description

Colinz Laboratories Limited is a Mumbai-based pharmaceutical company founded in 1986 that produces and sells a broad range of medicines across both conventional and traditional Indian medicine systems. Its portfolio covers treatments for serious conditions such as cancer and HIV, alongside everyday medicines for infections, pain, digestion, and hormonal health. The company also offers herbal remedies and nutritional supplements designed to support overall wellbeing.

Key Fundamentals

EPS11.10
P/E6.22
ROE28.54
RPS23.08
ROIC2.90
ROA22.84
Interest Cover4.21
EBITDA, mln36.28
EV / EBITDA2.96
EV / EBIT3.09
Revenue, mln58.11
EV / Revenue1.85

Quote Details

Last 69.00
Change 1.75 (2.6%)
Open 59.00
Volume 4,521
Turnover 311,949
Average Volume 1,351.48

Financial Ratios

Pre-Tax Profit Margin59
Current Ratio3.93
Price / Book1.92
Price / Tangible Book1.92
Price / Free Cash Flow5.99
Debt / Equity0.04
Price / Sales3.33
PEG Ratio0.28

Financial Strength

Altman Z-Score6.63
Piotroski F-Score 6 / 9
Beneish M-Score-3.39
Price to Intrinsic Value0.86
Price to Lynch Fair Value0.28
Price to Graham Number1.79
Shiller PE Ratio35.05

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.43% 66 / 100   
1 Month -8% 45 / 100   
2 Months -13.7% 35 / 100   
6 Months 47.15% 92 / 100   
1 Year 64.32% 93 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog